Review
[Perspectives on recombinant live vaccines]
[Article in
Japanese]
Affiliations
- PMID: 18939488
Item in Clipboard
Review
[Perspectives on recombinant live vaccines]
[Article in
Japanese]
Nihon Rinsho.
2008 Oct.
Abstract
Although vaccination has resulted in the reduction of diseases outbreaks, low levels of undesirable side effects are still a cause of concern. Traditional vaccines are made of live, attenuated, killed or fragmented pathogens, but recent progress in genetic engineering technique has enabled us to develop live attenuated mutants of several viruses and bacteria as potential vaccine vectors for antigen delivery. Such live vectors offer the advantage of delivery in a single oral, intranasal or inhalational dose, stimulating both systemic and mucosal immune responses. Here we describe the recent developments of new vaccines using recombinant viral and bacterial vectors.
Similar articles
-
A review of the current status of enteric vaccines.P N G Med J. 1995 Dec;38(4):325-31. P N G Med J. 1995. PMID: 9522876 Review.
-
Advances in the development of bacterial vector technology.Expert Rev Vaccines. 2003 Feb;2(1):31-43. doi: 10.1586/14760584.2.1.31. Expert Rev Vaccines. 2003. PMID: 12901595 Review.
-
Recent advances in the development of live, attenuated bacterial vectors.Curr Opin Mol Ther. 2005 Feb;7(1):62-72. Curr Opin Mol Ther. 2005. PMID: 15732531 Review.
-
Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.Southeast Asian J Trop Med Public Health. 2009 Mar;40(2):273-81. Southeast Asian J Trop Med Public Health. 2009. PMID: 19323012
-
Recombinant vaccinia viruses as live virus vectors for vaccine antigens: memorandum from a WHO/USPHS/NIBSC meeting.Bull World Health Organ. 1985;63(3):471-7. Bull World Health Organ. 1985. PMID: 2994898 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources